Hideaki Ishii
Overview
Explore the profile of Hideaki Ishii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shintaku T, Nakayama M, Ishii H, Yagi M, Ikegami H
Cureus
. 2024 Dec;
16(11):e73480.
PMID: 39669852
This report presents the long-term (over 15 years) results of four Japanese patients who underwent total joint replacement for thumb carpometacarpal (CMC) joint arthritis. Four patients (mean age 60.5 years)...
2.
Ohnuma K, Hirano-Kodaira M, Bannai M, Shimizu Y, Yamada M, Kinoshita K, et al.
Anal Methods
. 2024 Nov;
16(47):8250-8267.
PMID: 39503331
The abuse of prohibited peptide-based drugs with a broad spectrum of chemical characteristics poses a significant concern for the horseracing industry. Recently, there has been a notable increase in positive...
3.
Shimada H, Ishii H, Doi T, Tsutsumimoto K, Nakakubo S, Kurita S, et al.
Geriatr Gerontol Int
. 2024 Oct;
24(11):1218-1222.
PMID: 39402863
Aim: Driving cessation is strongly associated with adverse health outcomes in older adults. Although numerous studies have focused on driving skill interventions for safe driving, the effects of interventions on...
4.
Takayama A, Ishizaka M, Kubo A, Sato M, Yakabi A, Tsukahara S, et al.
J Phys Ther Sci
. 2024 Sep;
36(9):526-529.
PMID: 39239419
[Purpose] This study aimed to clarify the association between phase angle (PhA) and the level of independence in daily living among institutionalized super older females requiring nursing care. [Participants and...
5.
Ishii H, Shigematsu R, Takemoto S, Ishikawa Y, Mizobe F, Nomura M, et al.
Curr Drug Metab
. 2024 Sep;
25(7):489-504.
PMID: 39238378
Objective: Osilodrostat, used to treat Cushing's disease, exhibits an anabolic effect, leading to its classification as a prohibited substance in horseracing and equestrian sports. This study reports the characterization of...
6.
Ishii H, Shigematsu R, Takemoto S, Ishikawa Y, Mizobe F, Nomura M, et al.
Bioanalysis
. 2024 Sep;
16(17-18):947-958.
PMID: 39235065
The use of osilodrostat, developed as a medication for Cushing's disease but categorized as an anabolic agent, is banned in horses by both the International Federation of Horseracing Authorities and...
7.
Uchida T, Kisugi T, Ishii H, Yamada M, Kinoshita K, Leung G
Rapid Commun Mass Spectrom
. 2024 Jun;
38(17):e9856.
PMID: 38945695
Rationale: To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range...
8.
Ishii H, Shintaku T, Yoshizawa S, Maeda T, Ikegami H
Cureus
. 2024 Feb;
16(2):e54734.
PMID: 38405659
Residual deformity of the trochlea after fractures of the distal end of the humerus in children is well known and is referred to as fishtail deformity. Despite numerous reports on...
9.
Ishii H, Ishikawa Y, Mizobe F, Nomura M, Yamanaka T, Tanabe S, et al.
Rapid Commun Mass Spectrom
. 2024 Feb;
38(5):e9695.
PMID: 38355879
Rationale: Osilodrostat is an inhibitor of 11-beta-hydroxylase (CYP11B) and is used for the treatment of Cushing's disease but also categorized as an anabolic agent. The use of osilodrostat is prohibited...
10.
Ishii H, Okubo Y, Doi T, Tsutsumimoto K, Nakakubo S, Kurita S, et al.
Geriatr Gerontol Int
. 2023 Oct;
23(11):771-778.
PMID: 37828779
The primary aim of this systematic review was to examine the efficacy of driving interventions with regard to a reduction in motor vehicle crashes and improvements in driving skills among...